14 January 2022: Database Analysis
H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
Zongkuo Li 12AE , Menglong Hu 12A , Jinhuan Qiu 12C , Junkai Feng 12C , Ruizhen Zhang 1C , Huifang Wu 1D , Guiming Hu 1D , Jingli Ren 1G*DOI: 10.12659/MSM.933447
Med Sci Monit 2022; 28:e933447
Figure 4 The expression level of H2AFZ in subgroups of patients with LUAD. (A–C) The expression of H2AFZ is grouped by pathological stage, T, and N classification based on TCGA-LUAD data. (D) Differential mRNA expression of H2AFZ in LUAD with different T classifications in GSE68465. R 4.1.0 software (R Development Core Team, Vienna).